MVA85A: characterising the innate immune responses after vaccination and the effect of TLR1 levels on the acquired antigen-specific immune response

MVA85A: characterising the innate immune responses after vaccination and the effect of TLR1 levels on the acquired antigen-specific immune response

Bibliográfalaš dieđut
Váldodahkkit:	Kostov, M, Lang, Z, Harris, S, Rowland, R, Meyer, J, Pathan, A, Minassian, A, Fletcher, H, Mcshane, H
Materiálatiipa:	Conference item
Almmustuhtton:	2011

Geahča maid

Roles for Treg expansion and HMGB1 signaling through the TLR1-2-6 axis in determining the magnitude of the antigen-specific immune response to MVA85A
Dahkki: Matsumiya, M, et al.
Almmustuhtton: (2013)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG-immunized adults vaccinated with a new tuberculosis vaccine, MVA85A.
Dahkki: de Cassan, S, et al.
Almmustuhtton: (2010)

Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans.
Dahkki: McShane, H, et al.
Almmustuhtton: (2004)

A common human TLR1 polymorphism regulates the innate immune response to lipopeptides.
Dahkki: Hawn, T, et al.
Almmustuhtton: (2007)

Signaling in the innate immune response
Dahkki: Kim, Dennis H.
Almmustuhtton: (2017)

Investigating the Induction of Vaccine-Induced Th17 and Regulatory T Cells in Healthy, Mycobacterium bovis BCG Immunized Adults Vaccinated with a New Tuberculosis Vaccine, MVA85A (vol 17, pg 1066, 2010)
Dahkki: de Cassan, S, et al.
Almmustuhtton: (2011)

Investigating the induction of vaccine-induced Th17 and regulatory T cells in healthy, Mycobacterium bovis BCG immunized adults vaccinated with a new tuberculosis vaccine, MVA85A (Clinical and Vaccine Immunology (2010) 17, 7, (1066-1073))
Dahkki: De Cassan, S, et al.
Almmustuhtton: (2011)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
Dahkki: Harris, S, et al.
Almmustuhtton: (2013)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
Dahkki: Harris, SA, et al.
Almmustuhtton: (2014)

Synergy between TLR9 and NOD2 innate immune responses is lost in genetic Crohn's disease.
Dahkki: van Heel, D, et al.
Almmustuhtton: (2005)

Innate immune responses to tuberculosis vaccines
Dahkki: Matsumiya, M
Almmustuhtton: (2014)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults.
Dahkki: Pathan, A, et al.
Almmustuhtton: (2012)

Elucidation of the role of microRNA in innate immune response and adaptive immune response.
Dahkki: Chew, Chun Cheong.
Almmustuhtton: (2009)

A review of the tolerability of the candidate TB vaccine, MVA85A compared with BCG and Yellow Fever vaccines, and correlation between MVA85A vaccine reactogenicity and cellular immunogenicity
Dahkki: Rowland, R, et al.
Almmustuhtton: (2012)

Effect of vaccine dose on the safety and immunogenicity of a candidate TB vaccine, MVA85A, in BCG vaccinated UK adults
Dahkki: Pathan, A, et al.
Almmustuhtton: (2012)

Activation of the innate immune response by endogenous retroviruses.
Dahkki: Hurst, T, et al.
Almmustuhtton: (2015)

Modelling and simulation of human innate immune response
Dahkki: Koh, Soon Joo.
Almmustuhtton: (2010)

Non-eosinophilic asthma and the innate immune response.
Dahkki: Pavord, I
Almmustuhtton: (2007)

PRMT5 controls the innate immune response
Dahkki: Zhang, C
Almmustuhtton: (2024)

Innate immunity antigen recognition. Web alert.
Dahkki: Greaves, D
Almmustuhtton: (1998)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy.
Dahkki: Tchilian, E, et al.
Almmustuhtton: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
Dahkki: Tchilian, E, et al.
Almmustuhtton: (2013)

Immunization with different formulations of Mycobacterium tuberculosis antigen 85A induces immune responses with different specificity and protective efficacy
Dahkki: Tchilian, E, et al.
Almmustuhtton: (2013)

Boosting BCG with MVA85A: the first candidate subunit vaccine for tuberculosis in clinical trials.
Dahkki: Mcshane, H, et al.
Almmustuhtton: (2005)

Innate immune responses in primary HIV-1 infection.
Dahkki: Borrow, P, et al.
Almmustuhtton: (2008)

Enhancement of fracture repair by upregulation of the innate immune response
Dahkki: Santo, A, et al.
Almmustuhtton: (2014)

Modulation of innate immune responses by hepatitis C virus
Dahkki: Huston, L
Almmustuhtton: (2012)

Innate and adaptive immune responses in chronic HCV infection
Dahkki: Dustin, L
Almmustuhtton: (2015)

Pathogen recognition and signalling in the Drosophila innate immune response.
Dahkki: Wang, L, et al.
Almmustuhtton: (2006)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants
Dahkki: Odutola, A, et al.
Almmustuhtton: (2012)

A new TB vaccine, MVA85A, induces durable antigen-specific responses 14 months after vaccination in African infants.
Dahkki: Odutola, A, et al.
Almmustuhtton: (2012)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel Mycobacterium tuberculosis vaccine MVA85A.
Dahkki: Griffiths, K, et al.
Almmustuhtton: (2011)

Th1/Th17 cell induction and corresponding reduction in ATP consumption following vaccination with the novel mycobacterium tuberculosis vaccine MVA85A
Dahkki: Griffiths, K, et al.
Almmustuhtton: (2011)

CD4 T cell response to MVA85A vaccination against Mycobacterium tuberculosis in healthy HIV-infected adults
Dahkki: Beveridge, N, et al.
Almmustuhtton: (2011)

Genetic regulation of acquired immune responses to antigens of Mycobacterium tuberculosis: a study of twins in West Africa.
Dahkki: Jepson, A, et al.
Almmustuhtton: (2001)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses.
Dahkki: Tameris, M, et al.
Almmustuhtton: (2014)

The candidate TB vaccine, MVA85A, induces highly durable Th1 responses
Dahkki: Tameris, M, et al.
Almmustuhtton: (2014)

The innate immune effector cell response against HIV-1
Dahkki: Smalls-Mantey, A
Almmustuhtton: (2013)

Evaluating aerosol administration of a candidate TB vaccine, MVA85A, as a way to induce potent local cellular immune responses and avoid anti-vector immunity
Dahkki: Manjaly Thomas, ZR
Almmustuhtton: (2016)

Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-beta1.
Dahkki: Fletcher, H, et al.
Almmustuhtton: (2008)